- Ownership
-
Cardinal Health, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, September 16th, 2025 | 2023 | Jason M. Hollar Chief Executive Officer | 1,245,534 | 0 | 14,828,888 | 2,383,757 | 328,288 | 18,786,467 |
| Tuesday, September 16th, 2025 | 2024 | Jason M. Hollar Chief Executive Officer | 1,434,153 | 0 | 20,640,912 | 3,112,112 | 464,032 | 25,651,209 |
| Tuesday, September 16th, 2025 | 2025 | Jason M. Hollar Chief Executive Officer | 1,492,329 | 0 | 13,431,441 | 3,551,742 | 500,683 | 18,976,195 |
| Tuesday, September 16th, 2025 | 2023 | Jessica L. Mayer Chief Legal and Compliance Officer | 666,918 | 0 | 2,918,878 | 800,302 | 13,815 | 4,399,913 |
| Tuesday, September 16th, 2025 | 2024 | Jessica L. Mayer Chief Legal and Compliance Officer | 696,038 | 0 | 3,084,840 | 863,087 | 13,800 | 4,657,765 |
| Tuesday, September 16th, 2025 | 2025 | Jessica L. Mayer Chief Legal and Compliance Officer | 716,932 | 0 | 3,202,943 | 975,027 | 30,450 | 4,925,352 |
| Tuesday, September 16th, 2025 | 2023 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 606,139 | 0 | 2,672,523 | 773,979 | 19,020 | 4,071,661 |
| Tuesday, September 16th, 2025 | 2024 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 709,153 | 0 | 3,598,977 | 758,794 | 21,923 | 5,088,847 |
| Tuesday, September 16th, 2025 | 2025 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 741,932 | 0 | 3,771,217 | 964,511 | 30,197 | 5,507,857 |
| Tuesday, September 16th, 2025 | 2023 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 695,959 | 0 | 3,184,155 | 521,969 | 20,735 | 4,422,818 |
| Tuesday, September 16th, 2025 | 2024 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 721,038 | 0 | 5,973,322 | 627,303 | 16,150 | 7,337,813 |
| Tuesday, September 16th, 2025 | 2025 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 741,932 | 0 | 3,357,917 | 593,545 | 51,650 | 4,745,044 |
| Tuesday, September 16th, 2025 | 2023 | Aaron E. Alt Chief Financial Officer | 375,205 | 1,000,000 | 3,815,637 | 544,798 | 265,008 | 6,000,648 |
| Tuesday, September 16th, 2025 | 2024 | Aaron E. Alt Chief Financial Officer | 846,038 | 0 | 4,824,118 | 1,153,996 | 18,749 | 6,842,901 |
| Tuesday, September 16th, 2025 | 2025 | Aaron E. Alt Chief Financial Officer | 871,164 | 0 | 3,977,813 | 1,303,262 | 57,796 | 6,210,035 |
| Monday, September 16th, 2024 | 2023 | Jessica L. Mayer Chief Legal and Compliance Officer | 666,918 | 0 | 2,918,878 | 800,302 | 13,200 | 4,399,298 |
| Monday, September 16th, 2024 | 2022 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 666,781 | 0 | 2,762,792 | 166,695 | 15,403 | 3,611,671 |
| Monday, September 16th, 2024 | 2023 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 695,959 | 0 | 3,184,155 | 521,969 | 13,200 | 4,415,283 |
| Monday, September 16th, 2024 | 2024 | Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment | 721,038 | 0 | 5,973,322 | 627,303 | 13,800 | 7,335,463 |
| Monday, September 16th, 2024 | 2024 | Jessica L. Mayer Chief Legal and Compliance Officer | 696,038 | 0 | 3,084,840 | 863,087 | 13,800 | 4,657,765 |
| Monday, September 16th, 2024 | 2023 | Aaron E. Alt Chief Financial Officer | 375,205 | 1,000,000 | 3,815,637 | 544,798 | 265,008 | 6,000,648 |
| Monday, September 16th, 2024 | 2024 | Aaron E. Alt Chief Financial Officer | 846,038 | 0 | 4,824,118 | 1,153,996 | 17,849 | 6,842,001 |
| Monday, September 16th, 2024 | 2022 | Jason M. Hollar Chief Executive Officer | 729,247 | 0 | 2,762,792 | 320,869 | 69,791 | 3,882,699 |
| Monday, September 16th, 2024 | 2023 | Jason M. Hollar Chief Executive Officer | 1,245,534 | 0 | 14,828,888 | 2,383,757 | 325,588 | 18,783,767 |
| Monday, September 16th, 2024 | 2024 | Jason M. Hollar Chief Executive Officer | 1,434,153 | 0 | 20,640,912 | 3,112,112 | 463,532 | 25,650,709 |
| Monday, September 16th, 2024 | 2022 | Jessica L. Mayer Chief Legal and Compliance Officer | 616,781 | 0 | 4,261,614 | 244,245 | 12,426 | 5,135,066 |
| Monday, September 16th, 2024 | 2023 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 606,139 | 0 | 2,672,523 | 773,979 | 17,810 | 4,070,451 |
| Monday, September 16th, 2024 | 2024 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 709,153 | 0 | 3,598,977 | 758,794 | 19,063 | 5,085,987 |
| Wednesday, September 27th, 2023 | 2021 | Michael C. Kaufmann Former Chief Executive Officer | 1,300,000 | 0 | 10,197,832 | 780,000 | 204,546 | 12,482,378 |
| Wednesday, September 27th, 2023 | 2021 | Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer | 700,000 | 0 | 2,549,444 | 630,000 | 71,416 | 3,950,860 |
| Wednesday, September 27th, 2023 | 2022 | Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer | 729,247 | 0 | 2,762,792 | 320,869 | 69,791 | 3,882,699 |
| Wednesday, September 27th, 2023 | 2023 | Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer | 1,245,534 | 0 | 14,828,888 | 2,383,757 | 318,254 | 18,776,433 |
| Wednesday, September 27th, 2023 | 2021 | Jessica L. Mayer Chief Legal and Compliance Officer | 575,000 | 0 | 1,886,574 | 465,750 | 11,810 | 2,939,134 |
| Wednesday, September 27th, 2023 | 2022 | Jessica L. Mayer Chief Legal and Compliance Officer | 616,781 | 0 | 4,261,614 | 244,245 | 12,426 | 5,135,066 |
| Wednesday, September 27th, 2023 | 2023 | Jessica L. Mayer Chief Legal and Compliance Officer | 666,918 | 0 | 2,918,878 | 800,302 | 13,200 | 4,399,298 |
| Wednesday, September 27th, 2023 | 2021 | Stephen M. Mason Chief Executive Officer, Medical Segment | 625,000 | 0 | 2,549,444 | 562,500 | 17,256 | 3,754,200 |
| Wednesday, September 27th, 2023 | 2022 | Stephen M. Mason Chief Executive Officer, Medical Segment | 666,781 | 0 | 2,762,792 | 166,695 | 15,403 | 3,611,671 |
| Wednesday, September 27th, 2023 | 2021 | Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment | 725,000 | 0 | 2,804,433 | 652,500 | 35,894 | 4,217,827 |
| Wednesday, September 27th, 2023 | 2022 | Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment | 741,295 | 0 | 2,762,792 | 296,518 | 12,200 | 3,812,805 |
| Wednesday, September 27th, 2023 | 2023 | Aaron E. Alt Chief Financial Officer | 375,205 | 1,000,000 | 3,815,637 | 544,798 | 265,008 | 6,000,648 |
| Wednesday, September 27th, 2023 | 2023 | Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment | 280,673 | 0 | 3,184,155 | 0 | 1,304,776 | 4,769,604 |
| Wednesday, September 27th, 2023 | 2023 | Patricia M. English | 291,465 | 0 | 811,405 | 146,705 | 13,174 | 1,262,749 |
| Wednesday, September 27th, 2023 | 2022 | Michael C. Kaufmann Former Chief Executive Officer | 1,341,781 | 0 | 11,051,066 | 805,068 | 265,642 | 13,463,557 |
| Wednesday, September 27th, 2023 | 2023 | Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | 606,139 | 0 | 2,672,523 | 773,979 | 17,810 | 4,070,451 |
| Wednesday, September 27th, 2023 | 2023 | Michael C. Kaufmann Former Chief Executive Officer | 233,014 | 0 | 0 | 0 | 3,295,954 | 3,528,968 |
| Wednesday, September 27th, 2023 | 2023 | Stephen M. Mason Chief Executive Officer, Medical Segment | 695,959 | 0 | 3,184,155 | 521,969 | 13,200 | 4,415,283 |
| Wednesday, September 28th, 2022 | 2022 | Stephen M. Mason Chief Executive Officer — Medical Segment | 666,781 | 0 | 2,762,792 | 166,695 | 15,403 | 3,611,671 |
| Wednesday, September 28th, 2022 | 2021 | Stephen M. Mason Chief Executive Officer — Medical Segment | 625,000 | 0 | 2,549,444 | 562,500 | 17,256 | 3,754,200 |
| Wednesday, September 28th, 2022 | 2020 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 721,653 | 0 | 2,815,992 | 909,283 | 14,250 | 4,461,178 |
| Wednesday, September 28th, 2022 | 2021 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 725,000 | 0 | 2,804,433 | 652,500 | 35,894 | 4,217,827 |
| Wednesday, September 28th, 2022 | 2022 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 741,295 | 0 | 2,762,792 | 296,518 | 12,200 | 3,812,805 |
| Wednesday, September 28th, 2022 | 2020 | Jason M. Hollar Chief Financial Officer | 124,317 | 1,550,000 | 2,067,619 | 149,180 | 213,137 | 4,104,253 |
| Wednesday, September 28th, 2022 | 2021 | Jason M. Hollar Chief Financial Officer | 700,000 | 0 | 2,549,444 | 630,000 | 71,416 | 3,950,860 |
| Wednesday, September 28th, 2022 | 2021 | Michael C. Kaufmann Chief Executive Officer | 1,300,000 | 0 | 10,197,832 | 780,000 | 204,546 | 12,482,378 |
| Wednesday, September 28th, 2022 | 2022 | Jason M. Hollar Chief Financial Officer | 729,247 | 0 | 2,762,792 | 320,869 | 69,791 | 3,882,699 |
| Wednesday, September 28th, 2022 | 2020 | Michael C. Kaufmann Chief Executive Officer | 1,286,612 | 0 | 10,239,990 | 2,547,492 | 143,033 | 14,217,127 |
| Wednesday, September 28th, 2022 | 2022 | Michael C. Kaufmann Chief Executive Officer | 1,341,781 | 0 | 11,051,066 | 805,068 | 265,642 | 13,463,557 |
| Wednesday, September 28th, 2022 | 2020 | Stephen M. Mason Chief Executive Officer — Medical Segment | 511,749 | 0 | 2,304,024 | 586,348 | 21,350 | 3,423,471 |
| Wednesday, September 28th, 2022 | 2022 | Jessica L. Mayer Chief Legal and Compliance Officer | 616,781 | 0 | 4,261,614 | 244,245 | 12,426 | 5,135,066 |
| Wednesday, September 28th, 2022 | 2021 | Jessica L. Mayer Chief Legal and Compliance Officer | 575,000 | 0 | 1,886,574 | 465,750 | 11,810 | 2,939,134 |
| Wednesday, September 28th, 2022 | 2020 | Jessica L. Mayer Chief Legal and Compliance Officer | 547,268 | 0 | 1,792,014 | 559,061 | 15,859 | 2,914,202 |
| Thursday, September 23rd, 2021 | 2020 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 721,653 | 0 | 2,815,992 | 909,283 | 14,250 | 4,461,178 |
| Thursday, September 23rd, 2021 | 2020 | Jessica L. Mayer Chief Legal and Compliance Officer | 547,268 | 0 | 1,792,014 | 559,061 | 15,859 | 2,914,202 |
| Thursday, September 23rd, 2021 | 2021 | Jessica L. Mayer Chief Legal and Compliance Officer | 575,000 | 0 | 1,886,574 | 465,750 | 11,810 | 2,939,134 |
| Thursday, September 23rd, 2021 | 2021 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 725,000 | 0 | 2,804,433 | 652,500 | 35,894 | 4,217,827 |
| Thursday, September 23rd, 2021 | 2020 | Jason M. Hollar Chief Financial Officer | 124,317 | 1,550,000 | 2,067,619 | 149,180 | 213,137 | 4,104,253 |
| Thursday, September 23rd, 2021 | 2021 | Jason M. Hollar Chief Financial Officer | 700,000 | 0 | 2,549,444 | 630,000 | 71,416 | 3,950,860 |
| Thursday, September 23rd, 2021 | 2019 | Michael C. Kaufmann Chief Executive Officer | 1,193,288 | 0 | 12,110,701 | 2,126,439 | 140,576 | 15,571,004 |
| Thursday, September 23rd, 2021 | 2020 | Michael C. Kaufmann Chief Executive Officer | 1,286,612 | 0 | 10,239,990 | 2,547,492 | 143,033 | 14,217,127 |
| Thursday, September 23rd, 2021 | 2021 | Michael C. Kaufmann Chief Executive Officer | 1,300,000 | 0 | 10,197,832 | 780,000 | 204,546 | 12,482,378 |
| Thursday, September 23rd, 2021 | 2019 | Jessica L. Mayer Chief Legal and Compliance Officer | 429,856 | 0 | 2,152,539 | 364,933 | 19,707 | 2,967,035 |
| Thursday, September 23rd, 2021 | 2021 | Stephen M. Mason Chief Executive Officer — Medical Segment | 625,000 | 0 | 2,549,444 | 562,500 | 17,256 | 3,754,200 |
| Thursday, September 23rd, 2021 | 2020 | Stephen M. Mason Chief Executive Officer — Medical Segment | 511,749 | 0 | 2,304,024 | 586,348 | 21,350 | 3,423,471 |
| Thursday, September 23rd, 2021 | 2019 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 443,014 | 2,500,000 | 3,095,770 | 502,378 | 184,660 | 6,725,822 |
| Wednesday, September 23rd, 2020 | 2020 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 721,653 | 0 | 2,815,992 | 909,283 | 14,250 | 4,461,178 |
| Wednesday, September 23rd, 2020 | 2020 | Jason M. Hollar Chief Financial Officer | 124,317 | 1,550,000 | 2,067,619 | 149,180 | 213,137 | 4,104,253 |
| Wednesday, September 23rd, 2020 | 2019 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 443,014 | 2,500,000 | 3,095,770 | 502,378 | 184,660 | 6,725,822 |
| Wednesday, September 23rd, 2020 | 2020 | David C. Evans Former interim Chief Financial Officer | 2,178,361 | 0 | 0 | 0 | 26,850 | 2,205,211 |
| Wednesday, September 23rd, 2020 | 2020 | Jorge M. Gomez Former Chief Financial Officer | 65,574 | 0 | 0 | 0 | 2,951 | 68,525 |
| Wednesday, September 23rd, 2020 | 2018 | Jorge M. Gomez Former Chief Financial Officer | 478,149 | 0 | 1,294,742 | 387,356 | 37,527 | 2,361,293 |
| Wednesday, September 23rd, 2020 | 2020 | Michael C. Kaufmann Chief Executive Officer | 1,286,612 | 0 | 10,239,990 | 2,547,492 | 143,033 | 14,217,127 |
| Wednesday, September 23rd, 2020 | 2019 | Michael C. Kaufmann Chief Executive Officer | 1,193,288 | 0 | 12,110,701 | 2,126,439 | 140,576 | 15,571,004 |
| Wednesday, September 23rd, 2020 | 2019 | Jorge M. Gomez Former Chief Financial Officer | 593,288 | 0 | 2,530,734 | 0 | 26,757 | 3,150,779 |
| Wednesday, September 23rd, 2020 | 2018 | Michael C. Kaufmann Chief Executive Officer | 955,699 | 0 | 4,900,007 | 1,518,780 | 100,404 | 8,423,580 |
| Wednesday, September 23rd, 2020 | 2020 | Stephen M. Mason Chief Executive Officer — Medical Segment | 511,749 | 0 | 2,304,024 | 586,348 | 21,350 | 3,423,471 |
| Wednesday, September 23rd, 2020 | 2020 | Jessica L. Mayer Chief Legal and Compliance Officer | 547,268 | 0 | 1,792,014 | 559,061 | 15,859 | 2,914,202 |
| Wednesday, September 23rd, 2020 | 2019 | Jessica L. Mayer Chief Legal and Compliance Officer | 429,856 | 0 | 2,152,539 | 364,933 | 19,707 | 2,967,035 |
| Friday, September 20th, 2019 | 2017 | Jon L. Giacomin Former Chief Executive Officer — Medical Segment | 567,151 | 141,788 | 1,900,060 | 0 | 14,966 | 3,573,895 |
| Friday, September 20th, 2019 | 2019 | Craig S. Morford Former Chief Legal and Compliance Officer | 463,863 | 0 | 2,277,666 | 425,826 | 19,494 | 3,186,849 |
| Friday, September 20th, 2019 | 2019 | Jorge M. Gomez Former Chief Financial Officer | 593,288 | 0 | 2,530,734 | 0 | 26,757 | 3,150,779 |
| Friday, September 20th, 2019 | 2018 | Craig S. Morford Former Chief Legal and Compliance Officer | 585,205 | 0 | 1,110,842 | 608,848 | 31,514 | 2,929,750 |
| Friday, September 20th, 2019 | 2018 | Jorge M. Gomez Former Chief Financial Officer | 478,149 | 0 | 1,294,742 | 387,356 | 37,527 | 2,361,293 |
| Friday, September 20th, 2019 | 2019 | Jon L. Giacomin Former Chief Executive Officer — Medical Segment | 805,301 | 0 | 3,036,921 | 0 | 26,357 | 3,868,579 |
| Friday, September 20th, 2019 | 2019 | Victor L. Crawford Chief Executive Officer — Pharmaceutical Segment | 443,014 | 2,500,000 | 3,095,770 | 502,378 | 184,660 | 6,725,822 |
| Friday, September 20th, 2019 | 2019 | Jessica L. Mayer Chief Legal and Compliance Officer | 429,856 | 0 | 2,152,539 | 364,933 | 19,707 | 2,967,035 |
| Friday, September 20th, 2019 | 2017 | Michael C. Kaufmann Chief Executive Officer | 746,438 | 186,609 | 1,947,561 | 0 | 14,979 | 3,893,019 |
| Friday, September 20th, 2019 | 2018 | Michael C. Kaufmann Chief Executive Officer | 955,699 | 0 | 4,900,007 | 1,518,780 | 100,404 | 8,423,580 |
| Friday, September 20th, 2019 | 2019 | Michael C. Kaufmann Chief Executive Officer | 1,193,288 | 0 | 12,110,701 | 2,126,439 | 140,576 | 15,571,004 |
| Friday, September 20th, 2019 | 2017 | Craig S. Morford Former Chief Legal and Compliance Officer | 552,151 | 117,332 | 1,033,386 | 0 | 14,967 | 2,234,467 |
| Friday, September 20th, 2019 | 2018 | Jon L. Giacomin Former Chief Executive Officer — Medical Segment | 697,055 | 0 | 2,900,011 | 853,195 | 36,131 | 5,435,082 |
| Wednesday, September 26th, 2018 | 2017 | Donald M. Casey Jr. Former Chief Executive Officer — Medical Segment | 705,014 | 176,253 | 1,947,561 | 0 | 10,800 | 3,837,060 |
| Wednesday, September 26th, 2018 | 2017 | Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer | 746,438 | 186,609 | 1,947,561 | 0 | 14,979 | 3,893,019 |
| Wednesday, September 26th, 2018 | 2016 | Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer | 721,311 | 0 | 1,575,006 | 880,723 | 27,251 | 4,030,693 |
| Wednesday, September 26th, 2018 | 2018 | Jorge M. Gomez Chief Financial Officer | 478,149 | 0 | 1,294,742 | 387,356 | 37,527 | 2,361,293 |
| Wednesday, September 26th, 2018 | 2017 | George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer | 1,320,000 | 0 | 6,333,255 | 0 | 165,488 | 10,985,177 |
| Wednesday, September 26th, 2018 | 2016 | George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer | 1,320,000 | 0 | 6,491,739 | 2,386,755 | 131,928 | 13,661,087 |
| Wednesday, September 26th, 2018 | 2017 | Jon L. Giacomin Chief Executive Officer — Medical Segment | 567,151 | 141,788 | 1,900,060 | 0 | 14,966 | 3,573,895 |
| Wednesday, September 26th, 2018 | 2016 | Jon L. Giacomin Chief Executive Officer — Medical Segment | 542,623 | 0 | 1,400,062 | 602,314 | 27,770 | 3,273,965 |
| Wednesday, September 26th, 2018 | 2018 | Craig S. Morford Chief Legal and Compliance Officer | 585,205 | 0 | 1,110,842 | 608,848 | 31,514 | 2,929,750 |
| Wednesday, September 26th, 2018 | 2017 | Craig S. Morford Chief Legal and Compliance Officer | 552,151 | 117,332 | 1,033,386 | 0 | 14,967 | 2,234,467 |
| Wednesday, September 26th, 2018 | 2018 | George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer | 1,354,374 | 0 | 6,333,303 | 2,072,190 | 189,722 | 13,111,886 |
| Wednesday, September 26th, 2018 | 2018 | Jon L. Giacomin Chief Executive Officer — Medical Segment | 697,055 | 0 | 2,900,011 | 853,195 | 36,131 | 5,435,082 |
| Wednesday, September 26th, 2018 | 2018 | Patricia B. Morrison Retired Executive Vice President, Customer Support Services and Chief Information Officer | 530,356 | 0 | 1,095,811 | 432,771 | 30,705 | 2,824,482 |
| Wednesday, September 26th, 2018 | 2018 | Donald M. Casey Jr. Former Chief Executive Officer — Medical Segment | 440,411 | 0 | 1,900,031 | 0 | 3,051 | 3,292,183 |
| Wednesday, September 26th, 2018 | 2016 | Donald M. Casey Jr. Former Chief Executive Officer — Medical Segment | 671,311 | 0 | 1,505,062 | 894,188 | 22,830 | 3,899,760 |
| Wednesday, September 26th, 2018 | 2018 | Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer | 955,699 | 0 | 4,900,007 | 1,518,780 | 100,404 | 8,423,580 |
| Wednesday, September 26th, 2018 | 2016 | Craig S. Morford Chief Legal and Compliance Officer | 531,311 | 0 | 1,620,055 | 576,487 | 37,579 | 3,186,139 |
| Thursday, September 21st, 2017 | 2016 | Donald M. Casey Jr. Chief Executive Officer—Medical Segment | 671,311 | 0 | 1,505,062 | 894,188 | 22,830 | 3,899,760 |
| Thursday, September 21st, 2017 | 2017 | Jon L. Giacomin Chief Executive Officer—Pharmaceutical Segment | 567,151 | 141,788 | 1,900,060 | 0 | 14,966 | 3,573,895 |
| Thursday, September 21st, 2017 | 2017 | Craig S. Morford Chief Legal and Compliance Officer | 552,151 | 117,332 | 1,033,386 | 0 | 14,967 | 2,234,467 |
| Thursday, September 21st, 2017 | 2016 | Craig S. Morford Chief Legal and Compliance Officer | 531,311 | 0 | 1,620,055 | 576,487 | 37,579 | 3,186,139 |
| Thursday, September 21st, 2017 | 2015 | Craig S. Morford Chief Legal and Compliance Officer | 510,000 | 0 | 800,016 | 559,598 | 35,453 | 2,305,544 |
| Thursday, September 21st, 2017 | 2016 | Michael C. Kaufmann Chief Financial Officer | 721,311 | 0 | 1,575,006 | 880,723 | 27,251 | 4,030,693 |
| Thursday, September 21st, 2017 | 2017 | Donald M. Casey Jr. Chief Executive Officer—Medical Segment | 705,014 | 176,253 | 1,947,561 | 0 | 10,800 | 3,837,060 |
| Thursday, September 21st, 2017 | 2015 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 5,983,334 | 2,510,508 | 135,232 | 13,269,731 |
| Thursday, September 21st, 2017 | 2015 | Michael C. Kaufmann Chief Financial Officer | 688,630 | 0 | 4,540,005 | 1,053,260 | 36,338 | 7,159,251 |
| Thursday, September 21st, 2017 | 2016 | Jon L. Giacomin Chief Executive Officer—Pharmaceutical Segment | 542,623 | 0 | 1,400,062 | 602,314 | 27,770 | 3,273,965 |
| Thursday, September 21st, 2017 | 2015 | Jon L. Giacomin Chief Executive Officer—Pharmaceutical Segment | 480,685 | 0 | 1,237,482 | 679,692 | 37,170 | 3,064,333 |
| Thursday, September 21st, 2017 | 2017 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 6,333,255 | 0 | 165,488 | 10,985,177 |
| Thursday, September 21st, 2017 | 2016 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 6,491,739 | 2,386,755 | 131,928 | 13,661,087 |
| Thursday, September 21st, 2017 | 2017 | Michael C. Kaufmann Chief Financial Officer | 746,438 | 186,609 | 1,947,561 | 0 | 14,979 | 3,893,019 |
| Thursday, September 21st, 2017 | 2015 | Donald M. Casey Jr. Chief Executive Officer—Medical Segment | 650,000 | 0 | 3,005,055 | 618,118 | 31,653 | 5,110,793 |
| Friday, September 16th, 2016 | 2016 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 6,491,739 | 2,386,755 | 131,928 | 13,661,087 |
| Friday, September 16th, 2016 | 2016 | Michael C. Kaufmann Chief Financial Officer | 721,311 | 0 | 1,575,006 | 880,723 | 27,251 | 4,030,693 |
| Friday, September 16th, 2016 | 2015 | Michael C. Kaufmann Chief Financial Officer | 688,630 | 0 | 4,540,005 | 1,053,260 | 36,338 | 7,159,251 |
| Friday, September 16th, 2016 | 2016 | Jon L. Giacomin Chief Executive Officer — Pharmaceutical Segment | 542,623 | 0 | 1,400,062 | 602,314 | 27,770 | 3,273,965 |
| Friday, September 16th, 2016 | 2015 | Jon L. Giacomin Chief Executive Officer — Pharmaceutical Segment | 480,685 | 0 | 1,237,482 | 679,692 | 37,170 | 3,064,333 |
| Friday, September 16th, 2016 | 2016 | Craig S. Morford Chief Legal and Compliance Officer | 531,311 | 0 | 1,620,055 | 576,487 | 37,579 | 3,186,139 |
| Friday, September 16th, 2016 | 2015 | Craig S. Morford Chief Legal and Compliance Officer | 510,000 | 0 | 800,016 | 559,598 | 35,453 | 2,305,544 |
| Friday, September 16th, 2016 | 2014 | Craig S. Morford Chief Legal and Compliance Officer | 508,466 | 0 | 799,948 | 552,957 | 32,390 | 2,293,705 |
| Friday, September 16th, 2016 | 2014 | George S. Barrett Chairman and Chief Executive Officer | 1,314,630 | 0 | 5,533,321 | 2,601,983 | 132,440 | 12,448,618 |
| Friday, September 16th, 2016 | 2014 | Michael C. Kaufmann Chief Financial Officer | 647,699 | 0 | 1,400,013 | 1,229,008 | 32,290 | 4,008,907 |
| Friday, September 16th, 2016 | 2016 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 671,311 | 0 | 1,505,062 | 894,188 | 22,830 | 3,899,760 |
| Friday, September 16th, 2016 | 2015 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 650,000 | 0 | 3,005,055 | 618,118 | 31,653 | 5,110,793 |
| Friday, September 16th, 2016 | 2014 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 647,699 | 0 | 1,469,988 | 544,067 | 28,190 | 3,459,835 |
| Friday, September 16th, 2016 | 2015 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 5,983,334 | 2,510,508 | 135,232 | 13,269,731 |
| Tuesday, September 15th, 2015 | 2014 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 647,699 | 0 | 1,469,988 | 544,067 | 28,190 | 3,459,835 |
| Tuesday, September 15th, 2015 | 2013 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 635,000 | 0 | 1,400,038 | 525,780 | 36,991 | 3,280,300 |
| Tuesday, September 15th, 2015 | 2015 | Jon L. Giacomin Chief Executive Officer — Pharmaceutical Segment | 480,685 | 0 | 1,237,482 | 679,692 | 37,170 | 3,064,333 |
| Tuesday, September 15th, 2015 | 2015 | Craig S. Morford Chief Legal and Compliance Officer | 510,000 | 0 | 800,016 | 559,598 | 35,453 | 2,305,544 |
| Tuesday, September 15th, 2015 | 2014 | Craig S. Morford Chief Legal and Compliance Officer | 508,466 | 0 | 799,948 | 552,957 | 32,390 | 2,293,705 |
| Tuesday, September 15th, 2015 | 2013 | Craig S. Morford Chief Legal and Compliance Officer | 500,000 | 0 | 820,007 | 453,750 | 29,108 | 2,212,363 |
| Tuesday, September 15th, 2015 | 2013 | Jeffrey W. Henderson Former Chief Financial Officer | 740,000 | 0 | 1,674,169 | 846,153 | 29,108 | 4,125,486 |
| Tuesday, September 15th, 2015 | 2015 | Jeffrey W. Henderson Former Chief Financial Officer | 793,973 | 0 | 1,750,035 | 1,055,984 | 35,653 | 3,635,645 |
| Tuesday, September 15th, 2015 | 2014 | Jeffrey W. Henderson Former Chief Financial Officer | 756,932 | 0 | 1,633,366 | 1,152,429 | 32,190 | 4,391,464 |
| Tuesday, September 15th, 2015 | 2013 | George S. Barrett Chairman and Chief Executive Officer | 1,285,000 | 0 | 5,335,018 | 2,021,305 | 137,632 | 11,474,800 |
| Tuesday, September 15th, 2015 | 2015 | Michael C. Kaufmann Chief Financial Officer | 688,630 | 0 | 4,540,005 | 1,053,260 | 36,338 | 7,159,251 |
| Tuesday, September 15th, 2015 | 2015 | George S. Barrett Chairman and Chief Executive Officer | 1,320,000 | 0 | 5,983,334 | 2,510,508 | 135,232 | 13,269,731 |
| Tuesday, September 15th, 2015 | 2014 | George S. Barrett Chairman and Chief Executive Officer | 1,314,630 | 0 | 5,533,321 | 2,601,983 | 132,440 | 12,448,618 |
| Tuesday, September 15th, 2015 | 2014 | Michael C. Kaufmann Chief Financial Officer | 647,699 | 0 | 1,400,013 | 1,229,008 | 32,290 | 4,008,907 |
| Tuesday, September 15th, 2015 | 2013 | Michael C. Kaufmann Chief Financial Officer | 635,000 | 0 | 1,505,017 | 714,375 | 28,908 | 3,668,168 |
| Tuesday, September 15th, 2015 | 2015 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 650,000 | 0 | 3,005,055 | 618,118 | 31,653 | 5,110,793 |
| Tuesday, September 16th, 2014 | 2014 | George S. Barrett Chairman and Chief Executive Officer | 1,314,630 | 0 | 5,533,321 | 2,601,983 | 132,440 | 12,448,618 |
| Tuesday, September 16th, 2014 | 2013 | George S. Barrett Chairman and Chief Executive Officer | 1,285,000 | 0 | 5,335,018 | 2,021,305 | 137,632 | 11,474,800 |
| Tuesday, September 16th, 2014 | 2012 | George S. Barrett Chairman and Chief Executive Officer | 1,277,101 | 0 | 5,138,682 | 1,809,652 | 123,246 | 11,209,724 |
| Tuesday, September 16th, 2014 | 2014 | Jeffrey W. Henderson Chief Financial Officer | 756,932 | 0 | 1,633,366 | 1,152,429 | 32,190 | 4,391,464 |
| Tuesday, September 16th, 2014 | 2013 | Jeffrey W. Henderson Chief Financial Officer | 740,000 | 0 | 1,674,169 | 846,153 | 29,108 | 4,125,486 |
| Tuesday, September 16th, 2014 | 2012 | Jeffrey W. Henderson Chief Financial Officer | 736,776 | 0 | 1,663,168 | 722,777 | 22,849 | 3,977,086 |
| Tuesday, September 16th, 2014 | 2014 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 647,699 | 0 | 1,400,013 | 1,229,008 | 32,290 | 4,008,907 |
| Tuesday, September 16th, 2014 | 2014 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 647,699 | 0 | 1,469,988 | 544,067 | 28,190 | 3,459,835 |
| Tuesday, September 16th, 2014 | 2014 | Craig S. Morford Chief Legal and Compliance Officer | 508,466 | 0 | 799,948 | 552,957 | 32,390 | 2,293,705 |
| Tuesday, September 16th, 2014 | 2013 | Craig S. Morford Chief Legal and Compliance Officer | 500,000 | 0 | 820,007 | 453,750 | 29,108 | 2,212,363 |
| Tuesday, September 16th, 2014 | 2012 | Craig S. Morford Chief Legal and Compliance Officer | 495,970 | 0 | 712,524 | 405,455 | 24,629 | 1,994,791 |
| Tuesday, September 16th, 2014 | 2012 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 131,858 | 500,000 | 999,972 | 118,671 | 506,091 | 2,756,663 |
| Tuesday, September 16th, 2014 | 2013 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 635,000 | 0 | 1,400,038 | 525,780 | 36,991 | 3,280,300 |
| Tuesday, September 16th, 2014 | 2013 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 635,000 | 0 | 1,505,017 | 714,375 | 28,908 | 3,668,168 |
| Tuesday, September 16th, 2014 | 2012 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 629,358 | 0 | 1,441,773 | 628,729 | 23,349 | 3,436,925 |
| Tuesday, September 17th, 2013 | 2011 | Jeffrey W. Henderson Chief Financial Officer | 716,712 | 0 | 808,493 | 815,977 | 25,464 | 3,777,410 |
| Tuesday, September 17th, 2013 | 2013 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 635,000 | 0 | 1,505,017 | 714,375 | 28,908 | 3,668,168 |
| Tuesday, September 17th, 2013 | 2011 | George S. Barrett Chairman and Chief Executive Officer | 1,230,082 | 0 | 2,520,001 | 1,934,919 | 132,015 | 10,214,206 |
| Tuesday, September 17th, 2013 | 2012 | George S. Barrett Chairman and Chief Executive Officer | 1,277,101 | 0 | 5,138,682 | 1,809,652 | 123,246 | 11,209,724 |
| Tuesday, September 17th, 2013 | 2013 | Jeffrey W. Henderson Chief Financial Officer | 740,000 | 0 | 1,674,169 | 846,153 | 29,108 | 4,125,486 |
| Tuesday, September 17th, 2013 | 2013 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 635,000 | 0 | 1,400,038 | 525,780 | 36,991 | 3,280,300 |
| Tuesday, September 17th, 2013 | 2012 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 629,358 | 0 | 1,441,773 | 628,729 | 23,349 | 3,436,925 |
| Tuesday, September 17th, 2013 | 2011 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 596,712 | 0 | 669,913 | 804,756 | 27,813 | 3,268,115 |
| Tuesday, September 17th, 2013 | 2011 | Craig S. Morford Chief Legal and Compliance Officer | 470,890 | 0 | 354,387 | 388,485 | 25,964 | 1,239,726 |
| Tuesday, September 17th, 2013 | 2012 | Craig S. Morford Chief Legal and Compliance Officer | 495,970 | 0 | 712,524 | 405,455 | 24,629 | 1,994,791 |
| Tuesday, September 17th, 2013 | 2013 | Craig S. Morford Chief Legal and Compliance Officer | 500,000 | 0 | 820,007 | 453,750 | 29,108 | 2,212,363 |
| Tuesday, September 17th, 2013 | 2012 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 131,858 | 500,000 | 999,972 | 118,671 | 506,091 | 2,756,663 |
| Tuesday, September 17th, 2013 | 2012 | Jeffrey W. Henderson Chief Financial Officer | 736,776 | 0 | 1,663,168 | 722,777 | 22,849 | 3,977,086 |
| Tuesday, September 17th, 2013 | 2013 | George S. Barrett Chairman and Chief Executive Officer | 1,285,000 | 0 | 5,335,018 | 2,021,305 | 137,632 | 11,474,800 |
| Friday, September 14th, 2012 | 2012 | Michael A. Lynch Former Chief Executive Officer — Medical Segment | 584,548 | 0 | 1,461,575 | 431,396 | 58,757 | 3,249,992 |
| Friday, September 14th, 2012 | 2010 | Michael A. Lynch Former Chief Executive Officer — Medical Segment | 600,000 | 46,406 | 693,002 | 945,000 | 36,728 | 4,836,745 |
| Friday, September 14th, 2012 | 2011 | Michael A. Lynch Former Chief Executive Officer — Medical Segment | 615,041 | 0 | 692,994 | 359,799 | 28,234 | 2,905,295 |
| Friday, September 14th, 2012 | 2011 | George S. Barrett Chairman and Chief Executive Officer | 1,230,082 | 0 | 2,520,001 | 1,934,919 | 132,015 | 10,214,206 |
| Friday, September 14th, 2012 | 2010 | George S. Barrett Chairman and Chief Executive Officer | 1,162,397 | 121,874 | 4,270,012 | 2,795,565 | 194,690 | 14,702,082 |
| Friday, September 14th, 2012 | 2012 | George S. Barrett Chairman and Chief Executive Officer | 1,277,101 | 0 | 5,138,682 | 1,809,652 | 123,246 | 11,209,724 |
| Friday, September 14th, 2012 | 2010 | Jeffrey W. Henderson Chief Financial Officer | 700,000 | 105,000 | 808,494 | 1,165,500 | 37,128 | 5,522,322 |
| Friday, September 14th, 2012 | 2012 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 629,358 | 0 | 1,441,773 | 628,729 | 23,349 | 3,436,925 |
| Friday, September 14th, 2012 | 2011 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 596,712 | 0 | 669,913 | 804,756 | 27,813 | 3,268,115 |
| Friday, September 14th, 2012 | 2010 | Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment | 567,452 | 48,469 | 646,800 | 970,343 | 43,605 | 4,716,039 |
| Friday, September 14th, 2012 | 2012 | Donald M. Casey Jr. Chief Executive Officer — Medical Segment | 131,858 | 500,000 | 999,972 | 118,671 | 506,091 | 2,756,663 |
| Friday, September 14th, 2012 | 2012 | Craig S. Morford Chief Legal and Compliance Officer | 495,970 | 0 | 712,524 | 405,455 | 24,629 | 1,994,791 |
| Friday, September 14th, 2012 | 2011 | Craig S. Morford Chief Legal and Compliance Officer | 470,890 | 0 | 354,387 | 388,485 | 25,964 | 1,239,726 |
| Friday, September 14th, 2012 | 2012 | Jeffrey W. Henderson Chief Financial Officer | 736,776 | 0 | 1,663,168 | 722,777 | 22,849 | 3,977,086 |
| Friday, September 14th, 2012 | 2011 | Jeffrey W. Henderson Chief Financial Officer | 716,712 | 0 | 808,493 | 815,977 | 25,464 | 3,777,410 |
| Friday, September 14th, 2012 | 2010 | Craig S. Morford Chief Legal and Compliance Officer | 450,000 | 27,000 | 354,388 | 624,375 | 39,620 | 2,664,923 |
| Wednesday, September 14th, 2011 | 2010 | Craig S. Morford Chief Legal and Compliance Officer | 450,000 | 27,000 | 354,388 | 624,375 | 39,620 | 2,664,923 |
| Wednesday, September 14th, 2011 | 2011 | Jeffrey W. Henderson Chief Financial Officer | 716,712 | 0 | 808,493 | 815,977 | 25,464 | 3,777,410 |
| Wednesday, September 14th, 2011 | 2011 | George S. Barrett Chairman and Chief Executive Officer | 1,230,082 | 0 | 2,520,001 | 1,934,919 | 132,015 | 10,214,206 |
| Wednesday, September 14th, 2011 | 2011 | Craig S. Morford Chief Legal and Compliance Officer | 470,890 | 0 | 354,387 | 388,485 | 25,964 | 1,239,726 |
| Wednesday, September 14th, 2011 | 2010 | Jeffrey W. Henderson Chief Financial Officer | 700,000 | 105,000 | 808,494 | 1,165,500 | 37,128 | 5,522,322 |
| Wednesday, September 14th, 2011 | 2009 | George S. Barrett Chairman and Chief Executive Officer | 975,000 | 390,000 | 974,978 | 0 | 246,052 | 3,763,556 |
| Wednesday, September 14th, 2011 | 2011 | Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment | 596,712 | 0 | 669,913 | 804,756 | 27,813 | 3,268,115 |
| Wednesday, September 14th, 2011 | 2010 | George S. Barrett Chairman and Chief Executive Officer | 1,162,397 | 121,874 | 4,270,012 | 2,795,565 | 194,690 | 14,702,082 |
| Wednesday, September 14th, 2011 | 2010 | Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment | 567,452 | 48,469 | 646,800 | 970,343 | 43,605 | 4,716,039 |
| Wednesday, September 14th, 2011 | 2011 | Michael A. Lynch Chief Executive Officer— Medical Segment | 615,041 | 0 | 692,994 | 359,799 | 28,234 | 2,905,295 |
| Wednesday, September 14th, 2011 | 2010 | Michael A. Lynch Chief Executive Officer— Medical Segment | 600,000 | 46,406 | 693,002 | 945,000 | 36,728 | 4,836,745 |
| Wednesday, September 15th, 2010 | 2008 | George S. Barrett Chairman and Chief Executive Officer | 412,910 | 706,455 | 5,327,363 | 0 | 183,928 | 9,726,656 |
| Wednesday, September 15th, 2010 | 2009 | George S. Barrett Chairman and Chief Executive Officer | 975,000 | 390,000 | 974,978 | 0 | 246,052 | 3,763,556 |
| Wednesday, September 15th, 2010 | 2010 | George S. Barrett Chairman and Chief Executive Officer | 1,162,397 | 121,874 | 4,270,012 | 2,795,565 | 194,690 | 14,702,082 |
| Wednesday, September 15th, 2010 | 2010 | Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment | 567,452 | 48,469 | 646,800 | 970,343 | 43,605 | 4,714,039 |
| Wednesday, September 15th, 2010 | 2010 | Michael A. Lynch Chief Executive Officer— Medical Segment | 600,000 | 46,406 | 693,002 | 945,000 | 36,728 | 4,836,745 |
| Wednesday, September 15th, 2010 | 2010 | Craig S. Morford Chief Legal and Compliance Officer | 450,000 | 27,000 | 354,388 | 624,375 | 39,620 | 2,664,923 |
| Wednesday, September 15th, 2010 | 2008 | R. Kerry Clark Former Chairman and Chief Executive Officer | 1,441,257 | 691,804 | 2,941,816 | 0 | 246,801 | 9,734,536 |
| Wednesday, September 15th, 2010 | 2009 | R. Kerry Clark Former Chairman and Chief Executive Officer | 1,450,000 | 696,000 | 3,044,996 | 0 | 216,558 | 9,974,967 |
| Wednesday, September 15th, 2010 | 2010 | R. Kerry Clark Former Chairman and Chief Executive Officer | 250,274 | 380,625 | 0 | 0 | 8,014,184 | 8,645,083 |
| Wednesday, September 15th, 2010 | 2009 | Jeffrey W. Henderson Chief Financial Officer | 700,000 | 280,000 | 1,905,439 | 0 | 21,958 | 3,921,903 |
| Wednesday, September 15th, 2010 | 2010 | Jeffrey W. Henderson Chief Financial Officer | 700,000 | 105,000 | 808,494 | 1,165,500 | 37,128 | 5,522,322 |
| Thursday, September 24th, 2009 | 2008 | George S. Barrett Vice Chairman and Chief Executive Officer—Healthcare Supply Chain Services | 412,910 | 706,455 | 963,276 | 0 | 183,928 | 2,653,216 |
| Thursday, September 24th, 2009 | 2008 | David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products | 741,503 | 556,127 | 315,362 | 0 | 27,941 | 2,234,856 |
| Thursday, September 24th, 2009 | 2009 | Vivek Jain | 450,000 | 162,000 | 907,158 | 0 | 18,327 | 1,966,494 |
| Thursday, September 24th, 2009 | 2007 | David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products | 725,000 | 0 | 33,223 | 960,988 | 102,993 | 3,250,571 |
| Thursday, September 24th, 2009 | 2009 | Ivan K. Fong | 497,318 | 179,014 | 1,200,275 | 0 | 1,094,783 | 3,490,920 |
| Thursday, September 24th, 2009 | 2009 | David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products | 745,000 | 0 | 642,060 | 0 | 21,912 | 2,192,277 |
| Thursday, September 24th, 2009 | 2009 | Jeffrey W. Henderson Chief Financial Officer | 700,000 | 280,000 | 1,678,540 | 0 | 21,958 | 3,774,474 |
| Thursday, September 24th, 2009 | 2009 | R. Kerry Clark Chairman of the Board and Chief Executive Officer | 1,450,000 | 696,000 | 4,014,677 | 0 | 216,558 | 13,150,317 |
| Thursday, September 24th, 2009 | 2009 | George S. Barrett Vice Chairman and Chief Executive Officer—Healthcare Supply Chain Services | 975,000 | 390,000 | 2,261,185 | 0 | 246,052 | 5,246,159 |
| Monday, May 18th, 2009 | 2007 | R. Kerry Clark Chairman of the Board and Chief Executive Officer | 1,400,000 | 1,120,000 | 0 | 8,400,000 | 300,438 | 12,676,438 |
| Monday, May 18th, 2009 | 2008 | R. Kerry Clark Chairman of the Board and Chief Executive Officer | 1,441,257 | 691,804 | 0 | 9,806,174 | 246,801 | 12,186,036 |
| Monday, September 29th, 2008 | 2007 | R. Kerry Clark Chairman of the Board and Chief Executive Officer | 1,400,000 | 1,120,000 | 0 | 8,400,000 | 300,438 | 12,676,438 |
| Monday, September 29th, 2008 | 2008 | R. Kerry Clark Chairman of the Board and Chief Executive Officer | 1,441,257 | 691,804 | 0 | 9,806,174 | 246,801 | 12,186,036 |
| Friday, September 28th, 2007 | 2007 | Robert D. Walter Executive Chairman of the Board | 900,000 | 0 | 577,508 | 1,552,500 | 393,265 | 8,534,485 |
| Friday, September 28th, 2007 | 2007 | Mark W. Parrish Chief Executive Officer — Healthcare Supply Chain Services | 620,462 | 0 | 877,719 | 689,880 | 37,728 | 3,407,759 |
| Friday, September 28th, 2007 | 2007 | Jeffrey W. Henderson Chief Financial Officer | 653,365 | 0 | 757,031 | 788,184 | 32,371 | 3,211,643 |
| Friday, September 28th, 2007 | 2007 | R. Kerry Clark President and Chief Executive Officer | 1,400,000 | 1,120,000 | 2,575,137 | 1,456,000 | 300,438 | 10,822,835 |
| Friday, September 28th, 2007 | 2007 | David L. Schlotterbeck Chief Executive Officer — Clinical and Medical Products | 725,000 | 0 | 33,223 | 960,988 | 102,993 | 3,250,571 |
| Tuesday, October 3rd, 2006 | 2006 | David L. Schlotterbeck Chief Executive Officer—Pharmaceutical and Medical Products | 578,692 | 778,118 | 0 | 0 | 2,343,922 | 3,700,732 |
| Tuesday, October 3rd, 2006 | 2004 | George L. Fotiades Former President and Chief Operating Officer | 627,710 | 0 | 0 | 0 | 11,278 | 638,988 |
| Tuesday, October 3rd, 2006 | 2005 | George L. Fotiades Former President and Chief Operating Officer | 751,149 | 683,839 | 0 | 0 | 36,132 | 1,471,120 |
| Tuesday, October 3rd, 2006 | 2005 | Jeffrey W. Henderson Chief Financial Officer | 114,231 | 323,306 | 1,137,990 | 0 | 4,492 | 1,580,019 |
| Tuesday, October 3rd, 2006 | 2006 | Jeffrey W. Henderson Chief Financial Officer | 552,115 | 742,500 | 0 | 0 | 50,756 | 1,345,371 |
| Tuesday, October 3rd, 2006 | 2006 | George L. Fotiades Former President and Chief Operating Officer | 701,885 | 400,000 | 0 | 0 | 3,876,433 | 4,978,318 |
| Tuesday, October 3rd, 2006 | 2004 | Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services | 490,387 | 0 | 306,900 | 0 | 7,321 | 804,608 |
| Tuesday, October 3rd, 2006 | 2005 | Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services | 545,019 | 392,861 | 308,070 | 0 | 30,305 | 1,276,255 |
| Tuesday, October 3rd, 2006 | 2006 | Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services | 632,500 | 671,710 | 1,460,092 | 0 | 2,851,708 | 5,616,010 |
| Tuesday, October 3rd, 2006 | 2005 | Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer | 1,066,578 | 1,585,851 | 0 | 0 | 32,132 | 2,684,561 |
| Tuesday, October 3rd, 2006 | 2006 | Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer | 1,065,116 | 2,911,527 | 3,194,299 | 0 | 102,223 | 7,273,165 |
| Tuesday, October 3rd, 2006 | 2006 | R. Kerry Clark President and Chief Executive Officer | 296,154 | 460,274 | 7,725,410 | 0 | 17,189 | 8,499,027 |
| Tuesday, October 3rd, 2006 | 2005 | David L. Schlotterbeck Chief Executive Officer—Pharmaceutical and Medical Products | 560,000 | 539,269 | 0 | 0 | 22,200 | 1,121,469 |
| Tuesday, October 3rd, 2006 | 2004 | Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer | 1,037,500 | 0 | 0 | 0 | 12,349 | 1,049,849 |
| Monday, September 26th, 2005 | 2005 | Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services | 545,019 | 392,861 | 308,070 | 0 | 30,305 | 1,276,255 |
| Monday, September 26th, 2005 | 2005 | Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources | 467,581 | 303,375 | 440,100 | 0 | 29,243 | 1,240,299 |
| Monday, September 26th, 2005 | 2004 | Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources | 445,800 | 0 | 0 | 0 | 8,864 | 454,664 |
| Monday, September 26th, 2005 | 2003 | Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources | 433,685 | 279,068 | 0 | 0 | 34,061 | 746,814 |
| Monday, September 26th, 2005 | 2003 | George L. Fotiades President and Chief Operating Officer | 532,121 | 387,412 | 0 | 0 | 35,957 | 955,490 |
| Monday, September 26th, 2005 | 2004 | George L. Fotiades President and Chief Operating Officer | 627,710 | 0 | 0 | 0 | 11,278 | 638,988 |
| Monday, September 26th, 2005 | 2005 | Robert D. Walter Chairman and Chief Executive Officer | 1,066,578 | 1,585,851 | 0 | 0 | 32,132 | 2,684,561 |
| Monday, September 26th, 2005 | 2005 | George L. Fotiades President and Chief Operating Officer | 751,149 | 683,839 | 0 | 0 | 36,132 | 1,471,120 |
| Monday, September 26th, 2005 | 2003 | Robert D. Walter Chairman and Chief Executive Officer | 1,015,230 | 2,112,135 | 0 | 0 | 36,473 | 3,163,838 |
| Monday, September 26th, 2005 | 2003 | Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services | 446,701 | 247,562 | 0 | 0 | 29,512 | 723,775 |
| Monday, September 26th, 2005 | 2004 | Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services | 490,387 | 0 | 306,900 | 0 | 7,321 | 804,608 |
| Monday, September 26th, 2005 | 2005 | David L. Schlotterbeck Chief Executive Officer—Pharmaceutical and Medical Products | 560,000 | 539,269 | 0 | 0 | 22,200 | 1,121,469 |
| Monday, September 26th, 2005 | 2004 | Robert D. Walter Chairman and Chief Executive Officer | 1,037,500 | 0 | 0 | 0 | 12,349 | 1,049,849 |
